SANTA CLARA, Calif.--(BUSINESS WIRE)--PercAssist, Inc., a medical device company developing innovative technology for a minimally invasive, extravascular platform to provide hemodynamic support for ...

Centers with multidisciplinary teams created to rapidly respond to cardiogenic shock are more likely to use invasive hemodynamic monitoring and advanced mechanical circulatory support (MCS), but less ...

Cardiogenic shock is characterized by depression of cardiac function that leads to low blood pressure, coronary ischemia, and further decreased cardiac contractility resulting in tissue hypoxemia. The ...

Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality. In this multicenter trial, ...

Central hypovolemia, frequently resulting from blood loss or shifts in vascular volume, presents significant challenges in clinical and emergency settings. The body’s response involves a cascade of ...

Older pulse contour technologies have faced limitations in accuracy when it comes to cardiogenic shock, low flow, and arrhythmia. However, this study demonstrates that Retia Medical's MBA algorithm ...